Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena M H Chua

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemico-Biological Interactions|September 2, 2024
Effective parallel evaluation of molecular design, expression and bioactivity of novel recombinant butyrylcholinesterase medical countermeasuresJoanne L Allard, Miguel Aguirre, Ruchi Gupta, et al.
The Journal of Biological Chemistry|August 20, 2021
Structural features of Cryptococcus neoformans bifunctional GAR/AIR synthetase may present novel antifungal drug targetsSheena M H Chua, Maha S I Wizrah, Zhenyao Luo, et al.
Plos One|October 7, 2016
Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformansSamantha D M Arras, Sheena M H Chua, Maha S I Wizrah, et al.
Fungal Genetics and Biology : FG & B|March 27, 2022
Identification and characterisation of sPEPs in Cryptococcus neoformansPaige E Erpf, Sheena M H Chua, Toan K Phung, et al.
Fungal Genetics and Biology : FG & B|March 8, 2020
Broadening the spectrum of fluorescent protein tools for use in the encapsulated human fungal pathogen Cryptococcus neoformansGarrick W K Spencer, Sheena M H Chua, Paige E Erpf, et al.
The Journal of Biological Chemistry|September 5, 2022
AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformansMaha S I Wizrah, Sheena M H Chua, Zhenyao Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infectionsMario D Garcia, Sheena M H Chua, Yu-Shang Low, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemico-Biological Interactions|September 2, 2024
Effective parallel evaluation of molecular design, expression and bioactivity of novel recombinant butyrylcholinesterase medical countermeasuresJoanne L Allard, Miguel Aguirre, Ruchi Gupta, et al.
The Journal of Biological Chemistry|August 20, 2021
Structural features of Cryptococcus neoformans bifunctional GAR/AIR synthetase may present novel antifungal drug targetsSheena M H Chua, Maha S I Wizrah, Zhenyao Luo, et al.
Plos One|October 7, 2016
Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformansSamantha D M Arras, Sheena M H Chua, Maha S I Wizrah, et al.
Fungal Genetics and Biology : FG & B|March 27, 2022
Identification and characterisation of sPEPs in Cryptococcus neoformansPaige E Erpf, Sheena M H Chua, Toan K Phung, et al.
Fungal Genetics and Biology : FG & B|March 8, 2020
Broadening the spectrum of fluorescent protein tools for use in the encapsulated human fungal pathogen Cryptococcus neoformansGarrick W K Spencer, Sheena M H Chua, Paige E Erpf, et al.
The Journal of Biological Chemistry|September 5, 2022
AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformansMaha S I Wizrah, Sheena M H Chua, Zhenyao Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infectionsMario D Garcia, Sheena M H Chua, Yu-Shang Low, et al.
Pageof 1